Physicians from Karl Landsteiner University of Health Sciences in Krems (KL Krems, Austria) present results of the world’s most extensive study headed by the MedUni Vienna investigating the value of 5-aminolevulinic acid in surgery of brain metastases Krems (Austria), May…
Author: prandd
Opportunity NOx. New Pilot System for Smart Adsorption of Nitrogen Oxide From Exhaust Gases and Breathing Air Now With 15 Times Greater Capacity
Successful test in large city shows technology’s potential to avert car bans; installation in vehicle exhaust systems the ultimate goal Pasching (Austria) 13th May 2020.A specially developed filtration system that adsorbs harmful nitrogen oxide from ambient air has successfully come…
Marinomed receives FFG funding to research SARS-CoV-2 therapy based on Carragelose
Development of a Carragelose®-containing inhalation solution for therapy of patients suffering from a SARS-CoV-2 infection Available clinical data show that Carragelose®binds previously known coronaviruses and other viruses that trigger respiratory infections Austrian Research Promotion Agency (FFG) funds up to 45% of…
Viravaxx AG and the Medical University of Vienna have launched a project for an integrated platform for immune diagnosis and vaccination for COVID-19
Vienna (Austria), 21 April, 2020. Viravaxx AG, a clinical stage biopharmaceutical company based in Vienna, Austria, announced today that it has launched a project for combating COVID-19 together with the Medical University of Vienna. In this project an integrated immunodiagnostic and…
Cancer Immunotherapy Can Cause Heart Muscle Damage
Doctors at Karl Landsteiner University of Health Sciences in Krems (Austria) review data on immune reactions in heart muscle inflammation. Krems (Austria), 16. April 2020 – Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the…
Marinomed with record sales in 2019 and positive outlook for 2020
Covid-19 will sustainably change in dealing with viral infections of the respiratory tract Strong demand for Carragelose®products Marinosolv®technology extended to further areas of application 31% sales increase to EUR 6.14 million in the 2019 financial year Vienna, April 16, 2020.Marinomed Biotech…
Antioxidant Does Not Withstand Oxygen: Storability of Vegetable Carotene Severely Affected by Oxygen in Air
EQ BOKU’s high-tech equipment at the University of Natural Resources and Life Sciences, Vienna enables precise analysis of factors influencing the storability of natural colouring concentrates. Vienna, 31 July 2019 – The shelf life of vegetable carotenoids when stored in…
EU Healthcare Systems: a Reallocation Of Resources Is Urgently Needed
Turning away from “low-value†(waste, overuse) towards “high-value†health care is critical for the sustainability of solidarity-based healthcare systems. The Ludwig Boltzmann Institute for Health Technology Assessment is represented on the European Expert Panel. Vienna, 11. July 2019 – On…
Investors Support Phage Therapy: Novel Approach to Solve the Antibiotics Crisis Receives Further Millions
Vienna (Austria), 27 June 2019: Austrian biotech company PhagoMed Biopharma GmbH successfully completed another financing round. PhagoMed, located at the Vienna Biocenter, is focused on developing virus-(phage-) based therapies against drug-resistant and chronic bacterial infections. Investors provided further EUR 1.5…
Psychological intervention study: even brief abstinence from social media causes withdrawal symptoms
Researchers from Karl Landsteiner University of Health Sciences identify addiction-like behaviour after time away from social media Krems (Austria), 14 November 2018 – In many cases, just a seven-day break from social media platforms such as Facebook and WhatsApp is…